Next Generation Sequencing in South Africa – The Future of Genomics with CPGR

Next Generation Sequencing in South Africa | CPGR

Understanding NGS: Next Generation Sequencing

Next Generation Sequencing (NGS), also known as high-throughput sequencing, is a revolutionary DNA sequencing technology that has transformed biological sciences. Unlike traditional methods that decode one DNA strand at a time, NGS allows massive parallel sequencing—meaning millions of DNA fragments can be analyzed simultaneously.

At CPGR (Centre for Proteomic and Genomic Research) in South Africa, we use NGS to decode genomes faster, more accurately, and at lower costs. From clinical diagnostics to academic research, NGS opens new possibilities in personalized medicine, cancer genomics, infectious disease tracking, and agricultural genomics.

Why South Africa Needs Next Generation Sequencing Now

South Africa faces unique health challenges—HIV, TB, cancer, and inherited diseases. Leveraging NGS Next Generation Sequencing enables faster, localized genomic research to improve diagnosis, treatment plans, and drug response insights.

Institutions like CPGR are driving the future by making NGS accessible for local labs, hospitals, universities, and biotech companies. Our Cape Town-based lab offers access to globally competitive sequencing capabilities right here in South Africa.

What Is Long Read Sequencing and Why It Matters

Long Read Sequencing is a newer advancement within the NGS field. While traditional NGS uses short reads (100–300 base pairs), long read sequencing allows the reading of fragments several thousand base pairs in length.

Why does that matter?

  • It improves accuracy in detecting structural variants
  • Resolves complex regions of the genome
  • Offers full-length transcriptome profiling
  • Enables de novo genome assembly without reference genomes

At CPGR, we offer both short-read NGS and long read sequencing solutions, using platforms like Oxford Nanopore and PacBio for comprehensive insights.

Applications of NGS and Long Read Sequencing in South Africa

1. Precision Medicine

NGS helps tailor treatments based on individual genetic profiles. In cancer genomics, sequencing tumor DNA reveals actionable mutations. CPGR offers gene panels designed for the South African population.

2. Infectious Disease Surveillance

During the COVID-19 pandemic, NGS was used to track variants in real time. In South Africa, the technology now assists in monitoring HIV, TB, and malaria mutations for public health decisions.

3. Rare and Inherited Disease Research

Many rare diseases go undiagnosed in South Africa due to lack of sequencing access. With NGS and long read sequencing, CPGR helps clinicians pinpoint rare mutations for accurate diagnoses.

4. Agricultural Genomics

South Africa’s agricultural sector can use NGS to sequence crops and livestock for better yields, drought resistance, and disease control. Long read sequencing helps decode plant genomes efficiently.

5. Academic and Clinical Research

Universities and hospitals in South Africa collaborate with CPGR for high-quality, affordable sequencing services. We support projects ranging from gene expression to epigenetic analysis.

Why Choose CPGR for Next Generation Sequencing in South Africa

CPGR combines cutting-edge sequencing technologies, experienced scientists, and a deep understanding of local needs. We ensure that South African researchers and clinicians have access to globally competitive genomic infrastructure without needing to outsource internationally.

  • Accredited lab located in Cape Town
  • Expertise in both NGS and long read sequencing
  • End-to-end support from sample prep to bioinformatics
  • Tailored panels for South African genetic diversity

Future of NGS Next Generation Sequencing in South Africa

As genome analysis costs drop and technologies advance, NGS will become routine in hospitals and research. Long read sequencing will further enhance our ability to understand full genomes, detect rare variants, and solve complex biological puzzles.

With CPGR leading the way, South Africa is well-positioned to become a genomics innovation hub on the continent.

FAQs About NGS and Long Read Sequencing

What is NGS Next Generation Sequencing used for?

NGS is used to sequence DNA or RNA quickly and efficiently for research, diagnostics, and personalized medicine.

How does long read sequencing differ from short read NGS?

Long read sequencing reads longer DNA fragments, allowing for better genome assembly and detection of complex variants.

Is NGS available in South Africa?

Yes, CPGR offers world-class NGS and long read sequencing services in South Africa.

Can NGS detect genetic diseases?

Absolutely. NGS helps identify genetic mutations that cause inherited diseases, even those difficult to diagnose.

How can researchers in South Africa access NGS?

They can partner with CPGR in Cape Town for reliable, cost-effective sequencing solutions tailored to local research needs.

Final Note:

If you’re a researcher, clinician, or scientist in South Africa, now is the time to explore how Next Generation Sequencing and Long Read Sequencing can revolutionize your work. Partner with CPGR for high-impact results and future-ready solutions.Let the genomics revolution begin—right here in South Africa

CPGR Logo Icon

Not sure where to start?

Talk to a CPGR expert. We’ll match your goals with the right OMICS solution.

Year-End Closure Notice

CPGR will be closed:
•Friday, 12 December 2025, for our year-end function.
•Thursday, 18 December 2025, for the festive season.
 
CPGR will reopen:
•Monday, 05 January 2026.
  • New NGS Platform project requests (e.g., pricing) must be communicated and registered before 28 November 2025. Samples for ongoing projects must also be received by 28 November 2025. Reagents can be delivered until 17 December 2025. NGS operations will resume on 05 January 2026.
  • RT-PCR Platform will resume operations on 14 January 2026.
  • Proteomics Platform (D-CYPHR) will assist with new requests and project documentation until 12 December 2025 and closure on 19 December 2025. Proteomics operations will resume on 05 January 2025.
  • Microarray Platform sample batches must be received by CPGR on or before 08 December 2025 to ensure data is generated and sent out before our closing date. The Microarray operations will close on 18 December 2025 and resume on 05 January 2026.
  • Delivery of goods and services will take place before 17 December 2025 or after 05 January 2026.

Enjoy the festive season!